Search 
Saturday, July 05, 2008 ..:: Clinical Trials ::.. Register  Login
 Clinical Trials Minimize
 Print   
 Search Trials Minimize
 Print   
 Archives Minimize
Study Number:

Search
  
 Most Recent Entries Minimize
All Programs
All Sites - Prevention & Control (101170)
Sponsor: RTOG (0517)

 		By All Programs on 7/5/2008 10:00 AM
Randomized Phase Iii Trial To Evaluate Radiopharmaceuticals And Zoledronic Acid In The Palliation Of Osteoblastic Metastases From Lung, Breast, And Prostate Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
BMT
Multiple Sites (100715)
Sponsor: MUSC (100715)

 		By BMT on 7/5/2008 10:00 AM
Allogenic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Pre-transplant Conditioning for Patients Not Suitable for Full-Dose Pre-transplant Conditioning

None Available
More...
Breast
Breast (100899)
Sponsor: RTOG (0413)

 		By Breast on 7/5/2008 10:00 AM
A Radomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Vs Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Breast
Breast (100953)
Sponsor: MUSC (100953)

 		By Breast on 7/5/2008 10:00 AM
Myeloid Suppressor Cells in Breast Cancer

None Available
More...
Breast
Breast (101020)
Sponsor: Sanofi-Aventis (TCD6511)

 		By Breast on 7/5/2008 10:00 AM
A Dose-Escalating, Multicenter, Single Arm, Open-Label Study of XRP9881 in Combination with Capecitabine (Xeloda), in Metastatic Breast Cancer Patients with Disease Progressing After Anthracycline and Taxane Therapy

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101072)
Sponsor: Novelos (101072)

 		By Breast on 7/5/2008 10:00 AM
Phase II Study of Neoadjuvant Chemotherapy with NOV-002 and AC Followed by Docetaxel in Patients with Stage IIB-IIIC Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101136)
Sponsor: GlaxoSmithKilne (VEG108838)

 		By Breast on 7/5/2008 10:00 AM
A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 over-expressing Inflammatory Breast Cancer

HIPAA Authorization
Informed Consent
Informed Consent #2-Intervention
Informed Consent - Blood
Protocol
More...
Breast
Breast (101160)
Sponsor: ACOSOG (Z0131)

 		By Breast on 7/5/2008 10:00 AM
A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer

None Available
More...
Breast
Breast (101171)
Sponsor: CTSU/ECOG (PACCT-1)

 		By Breast on 7/5/2008 10:00 AM
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101172)
Sponsor: SWOG (S0622)

 		By Breast on 7/5/2008 10:00 AM
Phase II Studies of Two Different Schedules of Dasatinib (NSC-732517) in Bone-Metastasis Predominant Metastatic Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
 Print   
Copyright 2007 by Hollings Cancer Center   Terms Of Use  Privacy Statement